Pitfalls in lactate measurements at 3T
- PMID: 16611787
- PMCID: PMC8133981
Pitfalls in lactate measurements at 3T
Abstract
In clinical MR spectroscopy at higher field strengths, lactate may show reduced or absent signal intensity at an echo time of 144 ms. Although this false-negative result may be predicted from theory, experimental verification and clinical impact have not been fully established. Using scanners from 3 major vendors, spectra from phantoms and patients demonstrate the lactate signal loss and potential error in interpretation. Strategies are discussed to overcome, or at least alleviate, this problem.
Figures
References
-
- de Graaf R. In Vivo NMR Spectroscopy: Principles and Techniques. Chichester, UK: John Wiley and Sons Ltd;1998. :53–57
-
- Allen PS, Thompson RB, Wilman AH. Metabolite-specific NMR spectroscopy in vivo. NMR Biomed 1997;10:435–44 - PubMed
-
- Yablonskiy DA, Neil JJ, Raichle ME, et al. Homonuclear J coupling effects in volume localized NMR spectroscopy: pitfalls and solutions. Magn Reson Med 1998;39:159–78 - PubMed
-
- Kelley DAC, Lawrence LW, Star-Lack JM. Lactate detection at 3T: compensating J coupling effects with BASING. J Magn Reson Imaging 1999;9:732–37 - PubMed
-
- Star-Lack J, Spielman D, Adalsteinsson E, et al. In vivo lactate editing with simultaneous detection of choline, creatine, NAA, and lipid singlets at 1.5 T using PRESS excitation with applications to the study of brain and head and neck tumors. J Magn Reson 1998;133:243–54 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical